Why is Definium Therapeutics, Inc. stock down today?
September 23, 2026
Definium Therapeutics, Inc.
DFTX · NMS · USD
vs. prev. close $40.32
Last updated Sep 23, 2026 20:00
Intraday Chart — 5-min intervals
DFTX · less than a minute ago
Definium Therapeutics, Inc. is down 6.62% today. Here's the likely setup
The news backdrop is active, led by "Weekly Roundup on the Cannabis Sector & Psychedelic Sector" and "Definium’s LSD Pill Clears a Second Anxiety Trial, and the Psychedelics Sector Is Watching"; the headline mix is leaning mixed. DFTX is showing a 6.62% decline today, putting the latest price near $37.65.
Across major indices, S&P 500: -0.8%, Nasdaq: -1.1%, Dow Jones: -0.7%, Shanghai: -0.3%, Hang Seng: -0.8%; that puts the market backdrop in a under pressure state.
The setup can change quickly as new filings, headlines, and market data arrive.
Key Factors
Auto-generated analysis · Not financial advice
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive·2 days agoneutral
Definium’s LSD Pill Clears a Second Anxiety Trial, and the Psychedelics Sector Is Watching
Insider Monkey·3 days agoneutral
Definium Therapeutics’ DT120 Hits Phase III Goals in Anxiety Study
MarketBeat·4 days agoneutralBiotech Midweek Pulse: XBI Loses Steam After Hot 2026 Run — Here Are The Stocks And Catalysts To Watch Next
Stocktwits·8 days agoneutral
Definium Reports Second Phase III Success in Anxiety Disorder Program
Zacks·8 days agoneutral
Definium Therapeutics (DFTX) Stock May Trade At A Premium Despite Phase 3 DT120 Results
Simply Wall St.·8 days agoneutral
Definium tees up regulatory submission for psychedelic on Phase III hat trick
Pharmaceutical Technology·8 days agoneutral
Definium tees up regulatory submission for psychedelic on Phase III hat trick
Clinical Trials Arena·8 days agoneutral
S&P 500
-0.75%
Nasdaq
-1.13%
Dow Jones
-0.68%
Shanghai
-0.34%
Hang Seng
-0.83%
Nikkei 225
+1.38%
FTSE 100
-0.03%
Nifty 50
+0.14%
DAX
-0.66%
OMX Stockholm
-0.57%
Search another stock